The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 17, 2019

Filed:

Dec. 28, 2016
Applicant:

Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences, Guangzhou, CN;

Inventors:

Jinyong Wang, Guangzhou, CN;

Dan Yang, Guangzhou, CN;

Yong Dong, Guangzhou, CN;

Fangxiao Hu, Guangzhou, CN;

Qianhao Zhao, Guangzhou, CN;

Mengyun Zhang, Guangzhou, CN;

Cui Lv, Guangzhou, CN;

Ying Wang, Guangzhou, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/85 (2006.01); C12N 15/867 (2006.01); C12N 5/0783 (2010.01); C12N 5/0781 (2010.01);
U.S. Cl.
CPC ...
C12N 15/867 (2013.01); C12N 5/0635 (2013.01); C12N 5/0637 (2013.01); C12N 2506/11 (2013.01); C12N 2510/00 (2013.01); C12N 2730/00041 (2013.01);
Abstract

The present invention relates to a method for inducing the transdifferentiation of B lymphoid cells into T lymphoid cells using transcription factor Hoxb5, and related products and applications thereof. The method of the present invention specifically comprises: introducing Hoxb5, a nucleic acid molecule encoding Hoxb5 or a construct comprising the nucleic acid molecule into the B lymphoid cells to obtain the B lymphoid cells with overexpressed Hoxb5; then implanting the obtained B lymphoid cells into the body of a subject to obtain regenerated T cell progenitor cells by way of transdifferentiation, and then the T cell progenitor cells differentiate into mature T cells with functions. The regenerated T cells obtained using the method of the present invention are not only functionally normal, but also show no risk of tumorigenesis or extremely low risk of tumorigenesis.


Find Patent Forward Citations

Loading…